XML 30 R45.htm IDEA: XBRL DOCUMENT v2.4.0.8
Guarantor Financial Statements - Condensed Consolidating Statement of Cash Flows (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash flows from operating activities:    
Net income $ 25,943 $ 40,758
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion and amortization 82,646 75,435
Accretion expense 7,555 8,263
Deferred income tax provision (benefit) 15,102 27,024
Settlement of asset retirement obligations (9,842) (14,880)
Non-cash stock compensation expense 2,247 2,296
Excess tax benefits   (104)
Non-cash derivative expense 448 1,385
Non-cash interest expense 4,070 4,041
Non-cash (income) loss from investment in subsidiaries     
Change in current income taxes   (9,402)
Change in intercompany receivables/payables     
(Increase) decrease in accounts receivable (18,602) 19,952
Decrease in other current assets 100 40
(Increase) decrease in inventory (928) 158
Increase (decrease) in accounts payable 1,293 2,004
Increase (decrease) in other current liabilities 5,820 (8,942)
Other (380) (1,262)
Net cash (used in) provided by operating activities 115,472 146,766
Cash flows from investing activities:    
Investment in oil and gas properties (287,175) (160,968)
Proceeds from sale of oil and gas properties, net of expenses 51,954   
Investment in fixed and other assets (1,654) (599)
Change in restricted funds (358)   
Net cash used in investing activities (237,233) (161,567)
Cash flows from financing activities:    
Deferred financing costs (126) (11)
Excess tax benefits   104
Net payments for share-based compensation (6,565) (3,465)
Net cash used in financing activities (6,691) (3,372)
Effect of exchange rate changes on cash (11)   
Net change in cash and cash equivalents (128,463) (18,173)
Cash and cash equivalents, beginning of period 331,224 279,526
Cash and cash equivalents, end of period 202,761 261,353
Parent [Member]
   
Cash flows from operating activities:    
Net income 25,943 40,758
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion and amortization 28,055 10,191
Accretion expense 68 93
Deferred income tax provision (benefit) (5,907) (4,941)
Non-cash stock compensation expense 2,247 2,296
Excess tax benefits   (104)
Non-cash interest expense 4,070 4,041
Non-cash (income) loss from investment in subsidiaries (37,345) (56,828)
Change in current income taxes   (9,402)
Change in intercompany receivables/payables (51,037) 122,912
(Increase) decrease in accounts receivable (24,762) 10,668
Decrease in other current assets 100 40
(Increase) decrease in inventory (928) 158
Increase (decrease) in accounts payable 1,501 (1,890)
Increase (decrease) in other current liabilities 5,212 (20,011)
Other 145 (761)
Net cash (used in) provided by operating activities (52,638) 97,220
Cash flows from investing activities:    
Investment in oil and gas properties (46,772) (111,458)
Proceeds from sale of oil and gas properties, net of expenses 9,700  
Investment in fixed and other assets (1,654) (599)
Net cash used in investing activities (38,726) (112,057)
Cash flows from financing activities:    
Deferred financing costs (126) (11)
Excess tax benefits   104
Net payments for share-based compensation (6,565) (3,465)
Net cash used in financing activities (6,691) (3,372)
Net change in cash and cash equivalents (98,055) (18,209)
Cash and cash equivalents, beginning of period 246,294 228,398
Cash and cash equivalents, end of period 148,239 210,189
Guarantor Subsidiary [Member]
   
Cash flows from operating activities:    
Net income 37,341 56,828
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion and amortization 54,591 65,244
Accretion expense 7,487 8,170
Deferred income tax provision (benefit) 21,009 31,965
Settlement of asset retirement obligations (9,842) (14,880)
Non-cash derivative expense 448 1,385
Change in intercompany receivables/payables 47,637 (122,912)
(Increase) decrease in accounts receivable 6,160 9,284
Increase (decrease) in accounts payable (208) 3,894
Increase (decrease) in other current liabilities 608 11,069
Other (525) (501)
Net cash (used in) provided by operating activities 164,706 49,546
Cash flows from investing activities:    
Investment in oil and gas properties (236,903) (49,510)
Proceeds from sale of oil and gas properties, net of expenses 42,254  
Net cash used in investing activities (194,649) (49,510)
Cash flows from financing activities:    
Net change in cash and cash equivalents (29,943) 36
Cash and cash equivalents, beginning of period 84,290 51,128
Cash and cash equivalents, end of period 54,347 51,164
Non-Guarantor Subsidiaries [Member]
   
Cash flows from operating activities:    
Net income 8  
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion and amortization     
Accretion expense     
Non-cash (income) loss from investment in subsidiaries (4)  
Change in intercompany receivables/payables 3,400  
Net cash (used in) provided by operating activities 3,404  
Cash flows from investing activities:    
Investment in oil and gas properties (3,500)  
Change in restricted funds (358)  
Investment in subsidiaries (3,955)  
Net cash used in investing activities (7,813)  
Cash flows from financing activities:    
Equity proceeds from parent 3,955  
Net cash used in financing activities 3,955  
Effect of exchange rate changes on cash (11)  
Net change in cash and cash equivalents (465)  
Cash and cash equivalents, beginning of period 640  
Cash and cash equivalents, end of period 175  
Consolidation, Eliminations [Member]
   
Cash flows from operating activities:    
Net income (37,349) (56,828)
Adjustments to reconcile net income to net cash provided by operating activities:    
Non-cash (income) loss from investment in subsidiaries 37,349 56,828
Cash flows from investing activities:    
Investment in subsidiaries 3,955  
Net cash used in investing activities 3,955  
Cash flows from financing activities:    
Equity proceeds from parent (3,955)  
Net cash used in financing activities (3,955)  
Cash and cash equivalents, end of period